Grutters JPC, Govers T, Nijboer J, Tummers M, van der Wilt GJ, Rovers MM. Problems and promises of health technologies: the role of early health economic modeling.
Int J Health Policy Manag. 2019;8(10):575-582. doi:
10.15171/ijhpm.2019.36
Ijzerman MJ, Steuten LM. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
Appl Health Econ Health Policy. 2011;9(5):331-347. doi:
10.2165/11593380-000000000-00000
Callea G, Armeni P, Marsilio M, Jommi C, Tarricone R. The impact of HTA and procurement practices on the selection and prices of medical devices.
Soc Sci Med. 2017;174:89-95. doi:
10.1016/j.socscimed.2016.11.038
Cao Q, Postmus D, Hillege HL, Buskens E. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management.
Value Health. 2013;16(4):529-535. doi:
10.1016/j.jval.2013.02.008
Girling A, Young T, Brown C, Lilford R. Early-stage valuation of medical devices: the role of developmental uncertainty.
Value Health. 2010;13(5):585-591. doi:
10.1111/j.1524-4733.2010.00726.x
Markiewicz K, van Til JA, MJ IJ. Medical devices early assessment methods: systematic literature review.
Int J Technol Assess Health Care. 2014;30(2):137-146. doi:
10.1017/s0266462314000026
IJzerman MJ, Koffijberg H, Fenwick E, Krahn M. Emerging use of early health technology assessment in medical product development: a scoping review of the literature.
Pharmacoeconomics. 2017;35(7):727-740. doi:
10.1007/s40273-017-0509-1